Steven Itzkowitz
Affiliations: | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Physiology Biology, Medical BiophysicsGoogle:
"Steven Itzkowitz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wijnands AM, Penning de Vries BBL, Lutgens MWMD, et al. (2024) Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association |
Shaw DG, Aguirre-Gamboa R, Vieira MC, et al. (2023) Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nature Medicine |
Itzkowitz S, Farraye FA, Limburg P, et al. (2023) Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study. Journal of Crohn's & Colitis |
Shah SC, Itzkowitz SH. (2021) Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology. 162: 715-730.e3 |
Axelrad JE, Faye A, Slaughter JC, et al. (2021) Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Inflammatory Bowel Diseases |
Mahmoud R, Itzkowitz SH. (2021) Editorial: missed opportunities to detect colorectal cancer in inflammatory bowel disease-getting to the root. Alimentary Pharmacology & Therapeutics. 53: 335-336 |
Shah SC, Itzkowitz SH. (2020) Reappraising risk factors for inflammatory bowel disease-associated neoplasia: Implications for colonoscopic surveillance in IBD. Journal of Crohn's & Colitis |
Axelrad J, Colombel JF, Scherl E, et al. (2020) P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr Journal of Crohns & Colitis. 14 |
Axelrad JE, Colombel JF, Scherl EJ, et al. (2020) Su1849 THE SAPPHIRE REGISTRY: SAFETY OF IMMUNOSUPPRESSION IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH A HISTORY OF CANCER Gastroenterology. 158: S-673-S-674 |
Ungaro RC, Ho M, Stanley S, et al. (2020) Sa1761 AN INTERDISCIPLINARY CARE PROGRAM FOR RECENTLY DIAGNOSED INFLAMMATORY BOWEL DISEASE PATIENTS IS ASSOCIATED WITH INCREASED CLINICAL REMISSION RATES AND LOWER STEROID USE Gastroenterology. 158: S-413 |